Publications

Key environmental exposure pathways to antimicrobial resistant bacteria in southern Malawi: A SaniPath approach.

Mwapasa T, Chidziwisano K, Mphasa M, Cocker D, Rimella L, Amos S, Feasey N, Morse T,

Use of population pharmacokinetic-pharmacodynamic modelling to inform antimalarial dose optimization in infants.

Banda CG, Tarning J, Barnes KI,

Barriers and enablers to the effective implementation of omics research in low- and middle-income countries.

Nacis JS, Kamande P, Toni AT, Mudibo E, Musyimi R, Popluechai S, Dailey-Chwalibóg T, Voskuijl W, Dable-Tupas G, Shahid ASMSB, Bascos NA, Afroze F, Chisti MJ, Singa B, Ngari M, Tigoi C, Mhango G, Freitag H, Potani I, Mukisa J, Kirolos A, Mutasa K, Ouédraogo LO, Prentice AM, Girma T, Prendergast AJ, Njunge J, Kelly P, Berkley JA, Tickell KD, Gonzales GB,

Strategies for controlling pneumococcal disease and outbreaks during humanitarian emergencies.

Cliff M, Welaga P, Mohammed N, Ansah P, Heyderman RS, Trotter C, Kwambana-Adams B,

Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi.

Cave R, Kalizang’oma A, Chaguza C, Mwalukomo TS, Kamng’ona A, Brown C, Msefula J, Bonomali F, Nyirenda R, Swarthout TD, Kwambana-Adams B, French N, Heyderman RS,

Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions before, during, and after the COVID-19 pandemic.

Pitzer VE, Ndeketa L, Asare EO, Hungerford D, Jere KC, Cunliffe NA,

Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.

Burke RM, Nyirenda SK, Mtenga T, Twabi HH, Joekes E, Walker NF, Nyirenda R, Gupta-Wright A, Nliwasa M, Fielding K, MacPherson P, Corbett EL,

Longitudinal analysis within one hospital in sub-Saharan Africa over 20 years reveals repeated replacements of dominant clones of Klebsiella pneumoniae and stresses the importance to include temporal patterns for vaccine design considerations.

Heinz E, Pearse O, Zuza A, Bilima S, Msefula C, Musicha P, Siyabu P, Tewesa E, Graf FE, Lester R, Lissauer S, Cornick J, Lewis JM, Kawaza K, Thomson NR, Feasey NA,

Transcriptome profiles of Trypanosoma brucei rhodesiense in Malawi reveal focus specific gene expression profiles associated with pathology.

Nambala P, Noyes H, Namulondo J, Nyangiri O, Alibu VP, Nerima B, MacLeod A, Matovu E, Musaya J, Mulindwa J, TrypanoGEN+ Research Group as Members of the H3Africa Consortium,

HDV RNA and liver disease progression: What do we know?

Stockdale AJ, Degasperi E,